Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Ecolab reported a strong first quarter of 2026 characterized by 13% adjusted diluted earnings per share growth, with organic sales increasing 4% driven by 3% value pricing and accelerating volume growth of 1%.</li><li>The company demonstrated margin expansion, with organic operating income margins rising 70 basis points to 16.8%, supported by disciplined global execution and SG&A productivity gains.</li><li>Notably, the company’s “growth engines” such as Global High-Tech and Digital segments both grew over 20%, Life Sciences grew 11% led by bioprocessing with sales more than doubling, and Pest Elimination achieved 7% growth aided by new Pest Intelligence offerings.</li></ul>

Ecolab reported a strong first quarter of 2026 characterized by 13% adjusted diluted earnings per share growth, with organic sales increasing 4% driven by 3% value pricing and accelerating volume growth of 1%.The company demonstrated margin expansion, with organic operating income margins rising 70 basis points to 16.8%, supported by disciplined global execution and SG&A productivity gains.Notably, the company’s “growth engines” such as Global High-Tech and Digital segments both grew over 20%, Life Sciences grew 11% led by bioprocessing with sales more than doubling, and Pest Elimination achieved 7% growth aided by new Pest Intelligence offerings.

Ecolab: CoolIT And Ovivo Have Put It On The AI Data Center Water Map!

Ecolab Inc

Ecolab: CoolIT And Ovivo Have Put It On The AI Data Center Water Map!